Doctors operating on a patient with scan

Investor Relations

At Philips, we aim to deliver superior, long-term value to our customers and shareholders, while acting responsibly towards our planet and society, in partnership with our stakeholders.

May 16
Update on Philips Respironics’ PE-PUR sound abatement foam test and research program
 

Philips provided an update on Philips Respironics’ PE-PUR sound abatement foam test and research program. The press release, slide deck, frequently asked questions as well as other supporting materials can be found here.

 

The Company hosted an analyst call at 10:00 am CEST which can be accessed below.

Philips results

April 24
First quarter 2023 results publication 

Events


Upcoming events, conferences, and publications

Stock


Listing information, stock quote and chart, dividends, share repurchases and analyst coverage

Debt


Debt structure, bonds, ESG Framework, Euro Medium-Term Note (EMTN), Standby facility, credit rating

Environmental, Social & Governance


As a purpose-driven company, we have adopted a fully integrated approach to doing business responsibly and sustainably.

Respironics Field Action


We remain fully committed to implementing the necessary corrective actions for patients affected by the component quality issue in certain sleep and respiratory care devices.

Subscribe to receive alerts


To make sure you never miss our latest press releases or Investor Relations notifications, subscribe to our email updates.

Contact Investor Relations

For any other matters not directly related to Investor Relations, please visit our company contacts page.

You are about to visit a Philips global content page

Continue

You are about to visit a Philips global content page

Continue

Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.